Mölnlycke, a world-leading medical products and solutions company, is pleased to announce its acquisition of M&J Airlaid Products A/S (“M&J”).
Pressure ulcer prevention research
Recent studies carried out around the world have demonstrated the effectiveness of Mepilex® Border dressings in preventing hospital-acquired pressure ulcers.Read about PU study results
Did you know that around the world almost 8.5 million pressure ulcers occur in hospitals each year?
Annually, this causes USD 11 billion of pressure ulcer expenses. What’s more shocking is that many of these pressure ulcers and costs can be avoided. We can prevent unnecessary patient suffering – and at Mölnlycke, we’re doing something about it.
Imagine if hospitals could reduce their pressure ulcer rates by more than 80%
Our Mölnlycke® Prevention Programme equips healthcare professionals with knowledge, solutions and support – we make it easy to implement additional protocols in any existing prevention programmes. So hospitals can significantly reduce the rate of pressure ulcers and drive towards ambitious performance goals. It’s all about adopting best practice to save patients from unnecessary suffering. And reducing the waste of avoidable costs.